BG2997U1 - Medication administration kit - Google Patents

Abstract

This utility model relates to a medication administration kit. The kit comprises a box (1) which contains at least one medication administration device (4, 4a) and a video device (3). The video device is designed to provide visual or audio-visual instructions for use of the medication administration device (4, 4a). The medication administration device (4, 4a) as well as the video device (3) are movably attached to the box (1). Removing at least the one medication administration device (4, 4a) and the video device (3) from the box (1) allows the carrying of at least one medication administration device (4, 4a) and a video device (3) without having to carry the whole box (1). As to carry at least one medication administration device (4, 4a) and a video device (3) without the box (1) is much more convenient than carrying the whole bulky / heavy box (1), it is much more likely, in view of the foregoing state of the equipment, that the patient will carry the medication administration device (4, 4a) at all times so that the medication administration device (4, 4a) to be available as needed. Furthermore, as the video device can be removed from the bulky box (1), it is much more likely, in view of the foregoing state of the equipment, that the patient will also carry the video device (3). Hence that the likelihood of misuse of the medication administration device (4, 4a) also decreases compared to the foregoing state of the equipment.

Description

Self-administering devices such as pre-filled medical injection devices, inhalers, transdermal devices and the like are often used as part of the patient's treatment regimen. For example, devices known to us for self-administration of a drug can be used as part of an emergency treatment regimen for a patient. Emergency care may, for example, include the use of an automatic injectable agent for rapid administration of a drug in response to an allergic reaction, such as epinephrine, or for the treatment of another emergency, such as poisoning. Known devices for self-administration of the drug can be used as part of the treatment regimen of chronic patients. Modes for treating chronic conditions may include, for example, the use of a self-administering pen-injection device according to a prescribed schedule. Examples of chronic care regimens may include insulin injection, human growth hormone (HGH) injection, erythropoiesis stimulating agents (ESA), interferon and other chronic therapies, or the like. In addition, self-administering drugs can be used as a preventive / prophylactic therapy. Examples of such therapy include some vaccines, such as the influenza vaccine.

In order to activate some of our known drug delivery devices, the user has to perform a series of operations. For example, to activate some of the known auto-injection devices, the user must remove the protective cap, remove the locking device, place the auto-injection device in the correct position relative to the body and then press the auto-actuation button. -the injection device. If these actions are not performed correctly, the injection may be incomplete and / or in an inappropriate place on the body.

The likelihood of misuse of known drug delivery devices may also be increased by the nature of the user and / or the circumstances in which these devices are used. For example, most users are not trained medical professionals and may never have been trained to work with such devices. In addition, in some cases, the user may not be the patient himself and therefore may not have experience with the device for administering the drug. Also, because some of the known drug delivery devices are designed to be used relatively infrequently in response to an allergic reaction or the like, even users familiar with the device and / or trained may not have sufficient experience. with the device. Finally, these devices often have to be used in emergencies, where even experienced and / or trained users may be confused, panicked, and / or subjected to the physiological effects of the condition requiring treatment. It is important for the person in need of treatment to calm down and stop the panic by quickly and safely administering the necessary medication. It is also possible that people who have realized the seriousness of the situation are able to help the patient. At best, even some older people and children could also help the patient.

U.S. Pat. No. 9,278,177 B2 suggests that the likelihood of misuse of known drug delivery devices is significantly reduced if the drug delivery device is provided with an output device that transmits an audio-visual signal from a speaker and an LCD screen, indicating in sequence. instructions for use of the device for administration of the drug.

Document U S 9,278,177 B2 proposes that the drug delivery device and the output device be provided together as a medical kit in the form of a box that holds both the drug delivery device and the output device. However, according to the system proposed by U.S. Pat. No. 9,278,177 B2, the patient must carry the entire box in order to receive audio-visual instructions for use with the drug delivery device.

However, this is unprofitable, as such a box is bulky and carrying it is inconvenient and undesirable. Accordingly, the patient may not wear the device for administration of the drug

7754 Descriptions to utility model registration certificates № 10.1 / 15.10.2018 at any time so that the drug delivery device is not available if necessary. In addition, the patient can remove the drug delivery device from the box to carry only it and save on carrying the bulky box. However, in this case, audio-visual instructions for use of the drug delivery device will not be available when necessary and thus the likelihood of improper use of the drug delivery device increases.

The problems of the prior art are solved by the object of the claims. In particular, the problem is solved by a kit comprising a box 1 comprising at least one drug delivery device 4, 4a and a video device 3, characterized in that both devices are a drug delivery device 4, 4a as well as a video device. the device 3 are movably attached to the box 1.

A video device is a video viewer. As used herein, the term "video" means a series of images presented sequentially to convey visual instructions for use of the drug delivery device. There is no limit to the speed at which images are displayed sequentially. The images can be presented sequentially at a speed that causes the viewer to perceive the visual instructions for working with the drug delivery device as a film. That is, the speed at which the images follow may be such that the viewer perceives the visual instructions for using the drug delivery device as a continuous moving picture. Alternatively, the speed may be such that the visual instructions for using the drug delivery device are presented as a slide show. Ie the speed at which the images change may be such that the viewer perceives the moment when one image is replaced by the next as a sequence. In examples where the sequence is presented as a slide show, the presentation of the sequence may be automatic and / or involve the participation of the user to perform the replacement of one image with the next or previous in the series.

The kit of the present utility model includes a box 1. The box serves to compactly combine at least one drug delivery device 4,4a and the video device 3. In principle, any box 1 that is large enough to accommodate at least a drug delivery device 4, 4a and a video device 3. Preferably, the box is made of a durable material to protect at least one drug delivery device 4,4a and the video device 3 from damage by external forces. Preferred materials are selected from the group consisting of cardboard, plastic and metal.

Preferably, the kit includes a video access means 11 in addition to the video device. The video access means can be used to access a training video that contains visual instructions (video instructions) for working with the drug delivery device. As already described above, the training video can show a movie or a slide show. Preferably, the training video includes a movie. The video instructions are preferably a sequence of instructions for working with the drug delivery device 4, 4a.

The video device can be used to display video other than training. For example, a video device may display video at a rate at which images change so that the viewer perceives the moment one image changes to the next as a series, while training video can be viewed at a rate that causes the viewer to perceive. visual instructions for working with the drug delivery device as a film.

In exemplary embodiments involving a video access means 11, the box 1 is large enough to include at least one drug delivery device 4, 4a, a video device 3, and a video access means 11.

In some embodiments, the video access means includes a graphical representation containing information related to the video instructions for working with the drug delivery device 4, 4a. Preferably, the graphical representation presents data describing a reference to a place where the training video can be used. In some embodiments, this location is a unified resource identifier. For example, a unified resource identifier may be a unified resource locator (URL) that points to a web page (a "web address").

7755 Descriptions to utility registration certificates № 10.1 / 15.10.2018

In some embodiments, the graphic representation includes a barcode. The barcode can be two-dimensional (2D barcode). Ie the barcode may be a matrix barcode. Preferably, the barcode is a rapid response code (QR code). In these embodiments, the barcode provides data describing an indication of a location where video instructions can be viewed. Preferably, the URI is the URL for a web page where the training video can be viewed (ie the URI is the address of a web page).

The graphic representation must be machine recognizable. In some embodiments, the graphical representation can be read from a mobile device (eg, a mobile phone). By scanning the graphical representation, the mobile device can obtain information related to the video instructions for working with the drug delivery device.

In some embodiments, the video access means includes a data storage device that has a video with video instructions included for using the drug delivery device. The storage device can be any type of storage device. It may include electronic, magnetic, optical, and / or other type of data carrier / memory. For example, in some embodiments, the storage medium is an optical disc. In other embodiments, the storage medium is a solid state memory device, such as e.g. memory card. Preferably, the storage device is a USB device. In these embodiments, the storage device contains video data.

In some embodiments, the storage device (e.g., the USB device) contains only a training video, including video instructions for using the drug delivery device.

Alternatively, the storage device may further include a training video playback player that contains video instructions for using the drug delivery device. The player may be part of a hardware or software program for playing video data. In these embodiments, the storage device may be encoded with one or more programs that, when executed by one or more processors, cause the training video containing video instructions to play them.

The storage device 11 may include an integrated physical interface for transmitting data to a computer.

By providing a means of video access 11 in addition to the video device 3, the kit can provide the user with an even greater choice for watching the video instructions. In this way, the kit can offer better options to the user. In addition, the video access means can ensure reliability in the event that the video device does not function properly. This reduces the risk of improper use of the drug delivery device.

Preferably, the video instructions include audio-visual instructions for working with the drug delivery device.

Preferably, the box 1 of the present utility model can be closed. Thus, the box 1 is preferably with the possibility of reversible switching from the open to closed position and from the closed to open position. Preferably, the box 1 has a lid 2 shaped to close the box 1. Preferably, the lid 2 can be moved from the open position, where access to at least one drug delivery device 4, 4a and to a video is possible. device 3, to a closed position, in which access to at least one drug delivery device 4, 4a and to the video device 3 is prevented by the cover 2. Optionally, in the closed position, access to the video access means in the box 1 it is also prevented by the lid 2. Preferably, the lid 2 is moved from the open to the closed position by means of a hinge which connects the lid 2 to the housing of the box. Preferably, the cover 2 comprises a closing means 2a for fixing the cover 2 in the closed position by detachably attaching the cover 2 to the housing of the box 1. Preferably, the closing means 2a is located on the opposite end of the hinge. Preferably, the closing means 2a is designed to interact with the respective closing means on the housing of the box 1 so that the closing means 2a on the lid 2 and the corresponding closing means on the housing of the box 1 form a closing mechanism. Preferred closes

7756 Descriptions to utility registration certificates № 10.1 / 15.10.2018 cutting mechanisms are selected from the group consisting of magnetic locks, zippers and “velcro” patches.

Box 1 contains at least one drug delivery device 4, 4a. Preferably, the box 1 comprises exactly two drug delivery devices 4, 4a, preferably a first drug delivery device 4 and a second drug delivery device 4a. Preferably, the first drug delivery device 4 and the second drug delivery device 4a are interchangeable. Preferably, the drug delivery devices 4, 4a of the utility model are designed to provide drug delivery alone. Preferred drug delivery devices 4, 4a are selected from the group consisting of pre-filled medical injection devices, automatic syringes, inhalers and transdermal drug delivery devices.

Preferably, the drug delivery device 4, 4a comprises at least one active ingredient. Preferred active ingredients are from the group consisting of epinephrine, insulin, human growth hormone (HGH), erythropoiesis stimulating agents (ESA), interferons and vaccines, such as influenza vaccine. Even more preferably, the active ingredient is in the group consisting of epinephrine, insulin, human growth hormone (HGH) and erythropoiesis-stimulating agents (ESA).

The box 1 also comprises a video device 3. The video device 3 is preferably designed to provide visual or audio-visual instructions for working with the drug delivery device 4, 4a. Audio-visual instructions are preferred. The instructions are usually step-by-step instructions for working with the drug delivery device 4, 4a. The instructions for working with the drug delivery device 4, 4a are useful for reducing the likelihood of improper use of the drug delivery device 4, 4a.

The kit may include a means for initiating reproduction of the instructions for use of the drug delivery device when the box is open. Preferably, the kit includes a means for automatically starting the instructions for working with the drug delivery device from the video device when the box is open. For example, the kit may include a sensor configured to detect opening of the box and a controller configured to monitor playback of visual or audio-visual instructions from the video device in response to a signal from the sensor indicating that the box is open.

Preferably the video device 3 is relatively small. A relatively small video device 3 can be comfortably carried. Preferably, the size of the video device 3 is comparable to the size of the drug delivery device 4, 4a. This allows the video device 3 and the drug delivery device 4, 4a to be conveniently carried together. Preferably the length of the video device 3 is at most 200%, or more preferably at most 150%, and most preferably not more than 125%, preferably at most 110% of the length of the drug delivery device 4. , 4a. Preferably the width of the video device 3 is at most 200%, or more preferably at most 150%, more preferably not more than 125%, preferably at most 110% of the width of the drug delivery device 4. , 4a. Preferably the thickness of the video device 3 is at most 200%, or more preferably at most 150%, and most preferably not more than 125%, preferably at most 110% of the thickness of the drug delivery device 4. , 4a. Preferably the length of the video device 3 is at most 20 cm, or more preferably at most 15 cm, and most preferably not more than 12 cm, preferably at most 10 cm. Preferably the width of the video device 3 is at most 10 cm, more preferably at most 8 cm, more preferably not more than 6 cm, preferably at most 5 cm. Preferably the thickness of the video device 3 is at most 2 cm, preferably not more than 1.5 cm, preferably at most 1.2 cm, preferably at most 1 cm, preferably at most 0.8 cm, preferably not more of 0.5 cm, preferably not more than 0.2 cm. Preferably the dimensions of the video device 3 are not more than 20x10x2 cm, preferably at most 15x8x1.5 cm, preferably not more than 12x6x1 cm, and most preferably not more than 10x5x0.5 cm. For example, dimensions of at most 20x10x2 cm mean, according to the present description, that the Zee video device is not more than 20 cm long, not more than 10 cm wide and not more than 2 cm thick.

As at least one drug delivery device 4, 4a and the video device 3 are below

ΊΊ5Ί Descriptions to utility registration certificates № 10.1 / 15.10.2018 visibly attached to box 1. The removal of at least one of the drug delivery devices 4,4a and the video device 3 from the box 1 allows the transfer of at least one drug delivery device 4,4a and the video device 3 without the need to carry the whole box 1. Since carrying at least one drug delivery device 4, 4a and the video device 3 without the box 1 is much more -comfortable than carrying the entire bulky box 1 is more likely than the previous condition for the patient to carry the drug delivery device 4, 4a at any time, so that the drug delivery device 4, 4a is available if necessary. In addition, since the video device can be removed from the bulky box 1, it is more likely than in the prior art for the patient to carry the video device 3 so that instructions for use with the drug delivery device are available. if necessary. This reduces the likelihood of improper use of the drug delivery device 4, 4a compared to the prior art.

In embodiments in which the kit includes a video access means 11, the video access means is preferably movably attached to the box 1. This allows the video access means to be carried independently of the box 1, which may be more convenient than carrying of the whole box 1.

Preferably, at least one drug delivery device 4, 4a and the video device 3 are attached to the box 1 by means of fastening means. Preferably, the fastening means form part of the box 1. The fastening means 2b for the video device 3 are preferably located on the inner surface of the cover 2.

Optionally, the video access means 11 is also attached to the box 1 by means of attachments. Preferably, the video access means 11 is movably attached to the box 1 independently of the at least one drug delivery device 4,4a and the video device 3 so that the video access means can be removed from the box 1 independently of the at least one drug delivery device 4, 4a and the video device 3.

Preferably, the at least one drug delivery device 4, 4a and the video device 3 are attached to the box 1 in such a way that access to the at least one drug delivery device 4, 4a and the video device 3 is obstructed when the lid 2 is in the closed position. In this way, at least one drug delivery device 4, 4a and the video device 3 are protected from external forces if the lid 2 is in the closed position.

Preferably, the at least one drug delivery device 4, 4a and the video device 3 are movably attached to the box 1 in such a way that at least one drug delivery device 4, 4a and the video device 3 can be removed from the box 1 independently of each other. In this way, the patient can choose to wear at least one drug delivery device 4, 4a or the video device 3 or both. For example, for patients who have extensive experience with self-administration of the drug, it is not necessary to carry the video device 3. On the other hand, it may be useful if the video device 3 is worn separately, because then it can be used with purpose training without the need to wear an expensive and potentially sensitive drug delivery device 4, 4a. Furthermore, it may be disadvantageous to obtain the instructions from the video device 3 and administer the drug by means of the drug delivery device 4, 4a, when both the video device 3 and the drug delivery device 4, 4a are inextricably linked to each other. something else.

Preferably, the box 1 further comprises a free drug delivery device 6. This free device 6 may be useful for testing how the drug delivery device 4,4a is administered. Preferably, the free drug delivery device 6 has a construction similar to the drug delivery device 4, 4a. However, the free drug delivery device 6 does not contain any drug unlike the drug delivery device 4, 4a. Therefore, the patient can use the free drug delivery device 6 according to the instructions provided by the video device 3 to practice self-administration of the drug.

Preferably, the box 1 comprises another movable case 5 for at least one device for

7758 Descriptions to utility registration certificates № 10.1 / 15.10.2018 administration of drug 4, 4a and / or video device 3. Preferably this case 5 is a bag 5. Preferably the case 5 comprises a first compartment 9, which houses at least one drug delivery device 4,4a and a second compartment 10 in which the video device 3 is placed. This allows the video device 3 and the drug delivery device 4, 4a to be conveniently carried together. In some embodiments, the box 1 also comprises a third compartment into which the data storage device 11 enters.

Preferably, the first compartment 9 can be closed. Thus, the first compartment 9 preferably switches reversibly from the open position to the closed position and from the closed to the open position. Preferably, the first compartment 9 has a lid shaped to close the first compartment 9. Preferably, the lid is moved from the open position, where access to at least one drug delivery device 4, 4a in the first compartment 9 is possible, to the closed position, at which access to at least one drug delivery device 4, 4a in the first compartment 9 is prevented by the lid. Preferably, the cover is moved from the open to the closed position by means of a hinge which connects the cover to the housing of the cover 5. Preferably, the cover 5 includes a closing means 7 for reversibly fixing the cover in the closed position so that the first compartment 9 is closed. position. Preferred closures 7 are selected from the group consisting of magnetic fasteners, zippers and patch fasteners. Zippers are a particularly preferred closure 7.

Preferably, the second compartment 10 can be closed. Thus, the second compartment 10 can preferably reversely switch from the open position to the closed position and from the closed to the open position. Preferably, the case 5 comprises a closing means 8 formed for reversibly closing the second compartment 10, thus reversibly locking the second compartment 10 in the closed position. Preferably, the closing means 8 are moved from an open position in which access to the video device 3 in the second compartment 10 is possible to a closed position, in which access to the video device 3 in the second compartment 10 is obstructed by the closing means 8. Preferably the closing means 8 are selected from the group consisting of elastic bands, magnetic fasteners, zippers and patch fasteners. Particularly preferred closures 8 are elastic bands and magnetic clasps. Even more preferred closure means 8 are the elastic bands.

In preferred embodiments, the first compartment 9 and the second compartment 10 are closable.

The box 1 of the present utility model may also include a free drug delivery device 6 and a removable case 5 for at least one drug delivery device 4, 4a and / or a video device 3.

The present utility model will be further explained in relation to the preferred embodiments, as shown in Figures 1 to 5. Of course, the present utility model is not limited to the embodiments shown in the figures. Rather, these embodiments are preferred and representative embodiments that illustrate the inventive idea of the present utility model.

Figure 1 shows a diagram of the box 1 of the present utility model in perspective. In Figure 1, the box 1 is in the closed position and does not allow direct access to at least one drug delivery device 4, 4a and the video device 3 located in the box 1. The box 1 must be opened to gain access to at least one drug delivery device 4, 4a and the video device 3.

Figure 2 shows a schematic of the box 1 of the present utility model in perspective. Figure 2 illustrates schematically a preferred embodiment according to the present utility model. Figure 2 shows the box 1 in the open position. Therefore, the lid 2 is in the open position so that access to the drug delivery device 4, 4a and to the video device 3 in the box 1 is possible. According to the embodiment shown in Figure 2, the box 1 includes exactly two drug delivery devices 4. , 4a. The video device 3 is attached to the box 1 by means of fastening means 2b. The fastening means 2b for the video device 3 are located on the inner surface of the cover 2. The cover 2 is moved from the open position to the closed position by means of a hinge which connects

7759 Descriptions to utility registration certificates № 10.1 / 15.10.2018 cover 2 with box housing. The lid 2 has closing means 2a for fixing the lid 2 in the closed position by movably attaching the lid 2 to the housing of the box 1. The closing means 2a are located on the opposite side of the hinge. The box 1 further has a movable box 5 for the drug delivery device 4, 4a and for the video device 3. The box 1 further comprises a video access means 11 which is attached to the box. In this embodiment, the video access means is a matrix barcode, such as a QR code. When the matrix barcode is scanned using a mobile device, the mobile device is configured to open a web page at the URL stored by the matrix barcode. The website opens a training video that provides video instructions for working with the 4.4a drug delivery devices. In this way, with the help of a mobile device, you get quick access to the video instructions for working with the drug delivery device.

Figure 3 shows a diagram of the box 1 of the present utility model in perspective. Figure 3 shows the box 1 in the open position. Figure 3 shows a preferred embodiment according to the present utility model. Figure 3 shows an alternative embodiment to the embodiment shown in Figure 2. The box 1 shown in Figure 3 includes a free device 6 for administering the drug. Box 1 also has a USB device (not shown). The USB device stores a training video that provides video instructions for working with the drug delivery device.

Figure 4 shows a schematic of the box 1 of the present utility model in perspective. Figure 4 shows the box 1 in the open position. Figure 4 shows a preferred embodiment according to the present utility model. Figure 4 shows an alternative embodiment to the embodiments shown in Figures 2 and 3. The box 1 shown in Figure 4 includes neither a free drug delivery device 6 nor a removable case 5 for the drug delivery device 4, 4a and the video device. 3. In addition, box 1 has a USB device (not shown). The USB device stores a training video that provides video instructions for working with the drug delivery device.

Figure 5 shows in perspective a diagram of a movable case 5 for at least one drug delivery device 4, 4a and for a video device 3. The case 5 includes a first compartment 9, which houses at least one drug delivery device 4 , 4a and a second compartment 10 for the video device 3. The case 5 also has closing means 7 for reversibly closing the first compartment 9. The case 5 further comprises closing means 8 for reversing closing the second compartment 10.

List of reference box cover characters

2a means for closing the video device

4, 4A drug delivery device case free drug delivery device closure means closure means first compartment second compartment video access means

Claims (19)

Claims A drug delivery kit comprising a box (1) comprising at least one drug delivery device (4, 4a) and a video device (3), characterized in that both devices are a drug delivery device. drug (4, 4a) as well as the video device (3) are movably attached to the box (1). A kit according to claim 1, which also includes a video access means (11) in addition to the video device. 7760 Descriptions to certificates for registration of utility models № 10.1 / 15.10.2018 Kit according to claim 2, characterized in that the video access means (11) comprises one or both: (a) a graphic representation containing information relating to the video instructions for using the drug delivery device and ( (b) a data storage device containing video instructions for using the drug delivery device. Kit according to claim 2, characterized in that the graphical representation comprises a barcode, which is data describing a unified resource identifier (URI), wherein the barcode is preferably two-dimensional, and more preferably the barcode is a code for quick response (QR code). Kit according to claim 3, characterized in that the data storage device comprises an integrated interface for connection to a personal computer, wherein the data storage device is preferably a USB memory device. Kit according to any one of the preceding claims, characterized in that the box (1) is closed by a lid (2) which is moved from the open to the closed position. Kit according to claim 6, characterized in that the lid (2) comprises a closing means (2a) for fixing the lid (2) in the closed position by detachably attaching the lid (2) to the housing of the box (1). Kit according to claim 7, characterized in that the closing means (2a) are designed to interact with the respective closing means on the housing of the box (1), so that the closing means (2a) on the lid (2) and the corresponding means for closing on the housing of the box (1) form a closing mechanism selected from the group consisting of magnetic fasteners, zippers and patch fasteners. Kit according to at least one of the preceding claims, characterized in that the at least one drug delivery device (4, 4a) and the video device (3) are movably attached to the box (1) in such a way that access to at least one drug delivery device (4, 4a) and to the video device (3) is prevented when the lid (2) is in the closed position. Kit according to at least one of the preceding claims, characterized in that at least one of the drug delivery devices (4, 4a) and the video device (3) are movably attached to the box (1) in such a way that at least one drug delivery device (4,4a) and the video device (3) can be removed from the box (1) independently of each other. Kit according to at least one of the preceding claims, characterized in that the box (1) comprises a first drug delivery device (4) and a second drug delivery device (4a). Kit according to at least one of the preceding claims, characterized in that at least one of the drug delivery devices (4, 4a) is selected from the group consisting of pre-filled medical injection devices such as automatic syringes, inhalers and transdermal drug delivery devices. Kit according to at least one of the preceding claims, characterized in that at least one of the drug delivery devices (4, 4a) comprises at least one active ingredient. Kit according to at least one of the preceding claims, characterized in that the active ingredient is selected from the group consisting of epinephrine, insulin, human growth hormone (HGH) and erythropoiesis-stimulating agents (ESA). Kit according to at least one of the preceding claims, characterized in that the dimensions of the video device (3) are not more than 20x10x2 cm, preferably 15x8x1.5 cm and more preferably 12x6x1.2 cm. Kit according to at least one of the preceding claims, characterized in that the video device (3) is designed to provide visual or audio-visual instructions for use of the drug delivery device (4, 4a). Kit according to at least one of the preceding claims, characterized in that the box (1) comprises a further free drug delivery device (6). Kit according to at least one of the preceding claims, characterized in that the box (1) further comprises a movable case (5) for at least one drug delivery device (4, 4a) 7761 Descriptions to utility model registration certificates № 10.1 / 15.10.2018 and / or video device (3). Kit according to claim 9, characterized in that the case (5) comprises a first compartment (9) for placing at least one drug delivery device (4,4a) and a second compartment (10) for placing video the device (3).